首页 > 最新文献

JAMA最新文献

英文 中文
Trends and Disparities in Heat-Related Emergency Medical Services Activations 热相关紧急医疗服务激活的趋势和差异
Pub Date : 2026-02-04 DOI: 10.1001/jama.2025.26586
Chris Chaeha Lim, Jonathan A. Race, Parneet Kaur, Honghyok Kim, Ran Wei, Xiaojiang Li, Ladd Keith, Lynn B. Gerald, Brian Drummond, Noah M. Tolby, N. Clay Mann
This study compares US sociodemographic and geographic trends in heat-related and non–heat-related emergency medical services (EMS) activations from 2019 to 2024.
本研究比较了2019年至2024年美国热相关和非热相关紧急医疗服务(EMS)激活的社会人口和地理趋势。
{"title":"Trends and Disparities in Heat-Related Emergency Medical Services Activations","authors":"Chris Chaeha Lim, Jonathan A. Race, Parneet Kaur, Honghyok Kim, Ran Wei, Xiaojiang Li, Ladd Keith, Lynn B. Gerald, Brian Drummond, Noah M. Tolby, N. Clay Mann","doi":"10.1001/jama.2025.26586","DOIUrl":"https://doi.org/10.1001/jama.2025.26586","url":null,"abstract":"This study compares US sociodemographic and geographic trends in heat-related and non–heat-related emergency medical services (EMS) activations from 2019 to 2024.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"398 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Premenstrual Disorders 经期前疾病的管理
Pub Date : 2026-02-04 DOI: 10.1001/jama.2025.26054
Rebeca Ortiz Worthington, Lindsey M. Eastman, Jason T. Alexander
This JAMA Clinical Guidelines Synopsis summarizes the American College of Obstetricians and Gynecologists’ 2023 recommendations for management of premenstrual disorders.
本JAMA临床指南摘要总结了美国妇产科医师学会2023年对经前疾病管理的建议。
{"title":"Management of Premenstrual Disorders","authors":"Rebeca Ortiz Worthington, Lindsey M. Eastman, Jason T. Alexander","doi":"10.1001/jama.2025.26054","DOIUrl":"https://doi.org/10.1001/jama.2025.26054","url":null,"abstract":"This JAMA Clinical Guidelines Synopsis summarizes the American College of Obstetricians and Gynecologists’ 2023 recommendations for management of premenstrual disorders.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"287 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146116168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Pressure Above Goal Among US Adults With Hypertension 美国成人高血压患者血压高于目标
Pub Date : 2026-02-02 DOI: 10.1001/jama.2025.25657
Shakia T. Hardy, Byron C. Jaeger, Ezekiel Emanuel, Paul Muntner
This study used National Health and Nutrition Examination Survey 2021 to 2023 data to describe the proportion of US adults with uncontrolled blood pressure.
这项研究使用了2021年至2023年国家健康和营养检查调查的数据来描述美国成年人血压不受控制的比例。
{"title":"Blood Pressure Above Goal Among US Adults With Hypertension","authors":"Shakia T. Hardy, Byron C. Jaeger, Ezekiel Emanuel, Paul Muntner","doi":"10.1001/jama.2025.25657","DOIUrl":"https://doi.org/10.1001/jama.2025.25657","url":null,"abstract":"This study used National Health and Nutrition Examination Survey 2021 to 2023 data to describe the proportion of US adults with uncontrolled blood pressure.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"216 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146101441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma 机会性输卵管切除术预防输卵管性卵巢癌
Pub Date : 2026-02-02 DOI: 10.1001/jama.2025.24510
Jurgen M. Piek, Jolijn Schauwaert, Laura Burney Ellis, Ignacio Zapardiel, François Planchamp, Kata Koblos, Joanna Kacperczyk-Bartnik, Sarah J. Bowden, Houssein El Hajj, Mihaela Grigore, Miranda P. Steenbeek, Nicolò Bizzarri, Maria Kyrgiou, Murat Gültekin
Importance The fallopian tube epithelium has been demonstrated to be an important source of tubo-ovarian carcinoma. Therefore, removal of the fallopian tubes during unrelated pelvic or abdominal surgery (opportunistic salpingectomy) can potentially lower future ovarian cancer risk. Objectives To assess current evidence on the efficacy, risks, and long-term outcomes of opportunistic salpingectomy and to develop consensus statements for the European Society of Gynaecological Oncology. Evidence Review An international working group of 14 individuals including a patient representative was formed to develop consensus statements on opportunistic salpingectomy. The MEDLINE database was used to conduct a literature review of English-language studies from January 1, 2000, through March 1, 2025, evaluating opportunistic salpingectomy for reduction of tubo-ovarian carcinoma, complication rates, additional surgical time, and impact on ovarian function. Statements were subsequently drafted collaboratively based on the review of the literature and adapted in an iterative process in conference call meetings with opportunity for anonymous and nonanonymous feedback. The anonymous voting was binary (agree/disagree) for each potential statement. Final statements reached consensus with more than 75% agreement. Findings In the literature review, 230 studies were identified, of which 129 were deemed relevant to consensus statement development. Consensus was achieved on 18 statements, with grades of recommendation ranging from B to D and levels of evidence from II to V. Opportunistic salpingectomy is significantly associated with a lower risk of subsequent tubo-ovarian carcinoma, with no adverse short-term impact on ovarian function. The procedure appears safe across surgical approaches, with little additional operative time. Existing evidence does not indicate harm to ovarian function or premature menopause, although long-term evidence is not available. Salpingectomy is feasible during both gynecological and nongynecological procedures and should be considered in women undergoing gynecological surgery and, where possible, in women undergoing selected nongynecological pelvic or abdominal surgeries. Conclusions and Relevance Existing evidence demonstrates that opportunistic salpingectomy is significantly associated with a lower risk of developing tubo-ovarian carcinoma. Clinicians should include this prevention intervention in preoperative counseling of eligible women.
输卵管上皮已被证明是输卵管性卵巢癌的重要来源。因此,在不相关的盆腔或腹部手术中切除输卵管(机会性输卵管切除术)可以潜在地降低未来卵巢癌的风险。目的评估目前关于机会性输卵管切除术的疗效、风险和长期结果的证据,并为欧洲妇科肿瘤学会制定共识声明。一个由14人组成的国际工作组(包括一名患者代表)形成了关于机会性输卵管切除术的共识声明。MEDLINE数据库用于对2000年1月1日至2025年3月1日期间的英语研究进行文献综述,评估机会性输卵管切除术减少输卵管卵巢癌、并发症发生率、额外手术时间和对卵巢功能的影响。随后,在文献审查的基础上,共同起草了声明,并在电话会议的迭代过程中进行了修改,并有机会获得匿名和非匿名反馈。对于每个可能的陈述,匿名投票是二元的(同意/不同意)。最终声明达成了75%以上的一致意见。在文献综述中,确定了230项研究,其中129项被认为与共识声明的发展有关。18项声明达成共识,推荐等级从B到D,证据等级从II到v。机会性输卵管切除术与随后发生输卵管卵巢癌的风险较低显著相关,对卵巢功能没有不良的短期影响。该手术似乎是安全的,几乎没有额外的手术时间。尽管没有长期证据,但现有证据并未表明对卵巢功能或过早绝经有危害。输卵管切除术在妇科和非妇科手术中都是可行的,在接受妇科手术的妇女中,以及在可能的情况下,在接受特定的非妇科盆腔或腹部手术的妇女中,应考虑进行输卵管切除术。结论与意义已有证据表明,机会性输卵管切除术与较低的发生输卵管卵巢癌的风险显著相关。临床医生应将这种预防干预纳入对符合条件的妇女的术前咨询。
{"title":"Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma","authors":"Jurgen M. Piek, Jolijn Schauwaert, Laura Burney Ellis, Ignacio Zapardiel, François Planchamp, Kata Koblos, Joanna Kacperczyk-Bartnik, Sarah J. Bowden, Houssein El Hajj, Mihaela Grigore, Miranda P. Steenbeek, Nicolò Bizzarri, Maria Kyrgiou, Murat Gültekin","doi":"10.1001/jama.2025.24510","DOIUrl":"https://doi.org/10.1001/jama.2025.24510","url":null,"abstract":"Importance The fallopian tube epithelium has been demonstrated to be an important source of tubo-ovarian carcinoma. Therefore, removal of the fallopian tubes during unrelated pelvic or abdominal surgery (opportunistic salpingectomy) can potentially lower future ovarian cancer risk. Objectives To assess current evidence on the efficacy, risks, and long-term outcomes of opportunistic salpingectomy and to develop consensus statements for the European Society of Gynaecological Oncology. Evidence Review An international working group of 14 individuals including a patient representative was formed to develop consensus statements on opportunistic salpingectomy. The MEDLINE database was used to conduct a literature review of English-language studies from January 1, 2000, through March 1, 2025, evaluating opportunistic salpingectomy for reduction of tubo-ovarian carcinoma, complication rates, additional surgical time, and impact on ovarian function. Statements were subsequently drafted collaboratively based on the review of the literature and adapted in an iterative process in conference call meetings with opportunity for anonymous and nonanonymous feedback. The anonymous voting was binary (agree/disagree) for each potential statement. Final statements reached consensus with more than 75% agreement. Findings In the literature review, 230 studies were identified, of which 129 were deemed relevant to consensus statement development. Consensus was achieved on 18 statements, with grades of recommendation ranging from B to D and levels of evidence from II to V. Opportunistic salpingectomy is significantly associated with a lower risk of subsequent tubo-ovarian carcinoma, with no adverse short-term impact on ovarian function. The procedure appears safe across surgical approaches, with little additional operative time. Existing evidence does not indicate harm to ovarian function or premature menopause, although long-term evidence is not available. Salpingectomy is feasible during both gynecological and nongynecological procedures and should be considered in women undergoing gynecological surgery and, where possible, in women undergoing selected nongynecological pelvic or abdominal surgeries. Conclusions and Relevance Existing evidence demonstrates that opportunistic salpingectomy is significantly associated with a lower risk of developing tubo-ovarian carcinoma. Clinicians should include this prevention intervention in preoperative counseling of eligible women.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146101462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Care Plan Aims to Lower US Drug Costs and Increase Transparency. 医疗保健计划旨在降低美国药品成本并增加透明度。
Pub Date : 2026-01-30 DOI: 10.1001/jama.2025.26368
Samantha Anderer
{"title":"Health Care Plan Aims to Lower US Drug Costs and Increase Transparency.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.26368","DOIUrl":"https://doi.org/10.1001/jama.2025.26368","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year. 3种新的GLP-1减肥药的数据可能在今年被批准。
Pub Date : 2026-01-30 DOI: 10.1001/jama.2026.0287
Rita Rubin
{"title":"Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year.","authors":"Rita Rubin","doi":"10.1001/jama.2026.0287","DOIUrl":"https://doi.org/10.1001/jama.2026.0287","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"281 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146073061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Light Activity Lowers Death Risk in CKM Syndrome. 轻度运动降低CKM综合征的死亡风险
Pub Date : 2026-01-30 DOI: 10.1001/jama.2025.26369
Samantha Anderer
{"title":"Light Activity Lowers Death Risk in CKM Syndrome.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.26369","DOIUrl":"https://doi.org/10.1001/jama.2025.26369","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146073065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications. FDA要求从GLP-1 RA药物中删除自杀意念警告
Pub Date : 2026-01-30 DOI: 10.1001/jama.2025.26370
Samantha Anderer
{"title":"FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.26370","DOIUrl":"https://doi.org/10.1001/jama.2025.26370","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146073067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bariatric Surgery and GLP-1 Drugs Both Support Sustained Fat Loss. 减肥手术和GLP-1药物都支持持续减脂。
Pub Date : 2026-01-30 DOI: 10.1001/jama.2025.26367
Samantha Anderer
{"title":"Bariatric Surgery and GLP-1 Drugs Both Support Sustained Fat Loss.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.26367","DOIUrl":"https://doi.org/10.1001/jama.2025.26367","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
As US Overdose Deaths Drop, Researchers Search for Explanations. 随着美国过量死亡人数下降,研究人员寻找解释。
Pub Date : 2026-01-30 DOI: 10.1001/jama.2026.0553
Samantha Anderer
{"title":"As US Overdose Deaths Drop, Researchers Search for Explanations.","authors":"Samantha Anderer","doi":"10.1001/jama.2026.0553","DOIUrl":"https://doi.org/10.1001/jama.2026.0553","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"91 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146072939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1